CorMedix (CRMD) Shares Outstanding (2010 - 2026)
CorMedix (CRMD) posted Shares Outstanding (Entity) of $641000.0 for Q4 2025, down 99.18% sequentially from $78.3 million in Q3 2025, and down 99.0% YoY from $64.4 million in Q4 2024.
CorMedix (CRMD) Shares Outstanding (2010 - 2026) Analysis & Trends
CorMedix has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $641000.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) fell 99.0% year-over-year to $641000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $641000.0 (down 99.0% YoY) and the FY2025 annual result came in at $641000.0, down 99.0% from the prior year.
- Shares Outstanding (Entity) retreated to $641000.0 in Q4 2025 per CRMD's latest filing, from $78.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $78.3 million in Q3 2025 and troughed at $641000.0 in Q4 2025.
- A 5-year average of $48.5 million and a median of $45.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) jumped 45.77% in 2021, then sank 99.0% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $38.1 million in 2021, then gained by 12.42% to $42.8 million in 2022, then increased by 28.31% to $54.9 million in 2023, then grew by 17.24% to $64.4 million in 2024, then tumbled by 99.0% to $641000.0 in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $641000.0, $78.3 million, and $74.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 78.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72,034.00 |
| Dec 31, 2025 | 641,000.00 |
| Sep 30, 2025 | 76.40 Mn |
| Jun 30, 2025 | 67.93 Mn |
| Mar 31, 2025 | 65.24 Mn |
| Dec 31, 2024 | 58.87 Mn |
| Sep 30, 2024 | 58.83 Mn |
| Jun 30, 2024 | 57.62 Mn |
| Mar 31, 2024 | 57.50 Mn |
| Dec 31, 2023 | 50.90 Mn |
| Sep 30, 2023 | 56.55 Mn |
| Jun 30, 2023 | 45.37 Mn |
| Mar 31, 2023 | 44.09 Mn |
| Dec 31, 2022 | 40.27 Mn |
| Sep 30, 2022 | 41.18 Mn |
| Jun 30, 2022 | 39.76 Mn |
| Mar 31, 2022 | 38.25 Mn |
| Dec 31, 2021 | 37.67 Mn |
| Sep 30, 2021 | 38.11 Mn |
| Jun 30, 2021 | 38.08 Mn |